2018 Advances in Quantum Computing, Drug Delivery, and Investigational Therapies for Diabetes and Other Disorders - ResearchAndMarkets.com
The "Latest Advances in Quantum Computing, Drug Delivery, and Investigational Therapies for Diabetes and Other Disorders" report has been added to ResearchAndMarkets.com's offering.
The Life Science, Health & Wellness TOE depicts the current landscape and the new life sciences trends across twelve groundbreaking drug discovery and genetic platforms.
Each and every platform is accurately profiled covering the most cutting-edge technologies energizing the pharmaceutical landscape, such as quantum computing in life sciences, innovations in drug delivery, and novel investigational therapies for diabetes and other disorders.
1. Growth Opportunities in Life Sciences - Health & Wellness
- Exploring the Potential of Novel Platforms in Life Sciences
- Diamond Solutions for Nanoscale Imaging
- Quantum Sequencing Technology
- Quantum Machine Learning for Gene Regulation
- High-throughput Quantum Mechanics for Drug Discovery
- Preclinical Promise of JAK1 Inhibitor Drug for Asthma
- Clinical Study of a Gene Silencing Drug for Hepatitis B Infection
- Stem Cell-derived Replacement Therapy for Diabetes
- 510(k) Clearance for gammaCore for Prevention of Cluster Headaches
- Nanoparticle Delivery to Improve Osteoarthritis Regenerative Therapies
- Thymocyte Signaling Mechanism Discovery and Autoimmune Disorders
- Phase 3 Success of TALICIA for Helicobacter Pylori Infection
- Real-time Tumor Imaging Agent from Scorpion Venom
2. Industry Relations
- Regional Practice Leaders and Innovation Experts
For more information about this report visit https://www.researchandmarkets.com/research/khd8lx/2018_advances_in?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20190109005371/en/